NanoViricides

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-191
-195
-195
EBITDA
-2,025
-1,831
-2,931
EBIT
-2,216
-2,027
-3,126
Net Income
-2,095
-2,216
-2,027
-3,126
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,712
-1,990
-2,190
-2,641
Cash
1,558
2,542
3,958
3,866
Basic Shares
16,606
16,026
14,572
13,715

Annual Financials

Values in thousands 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-759
-747
-723
EBITDA
-9,591,645,000
-7,485
-7,840
-7,378
EBIT
-8,244
-8,587
-8,101
Net Income
-9,466,966,000
-8,294
-8,588
-8,100
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,535,643,000
-6,472
-5,821
-6,215
Cash
1,558,564,000
4,797
8,149
14,066
Basic Shares
15,117
11,871
11,626
11,534

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0
2025-03-31
-$0.13
2024-12-31
-$0.13